DPAGT1 and Congenital myasthenic syndromes: ARMCX4 interacts with DPAGT1, which suggests that ARMCX4 inhibits congenital myasthenic syndrome (CMS), GD, male infertility, and neonatal maxillofacial deformities by interacting with DPAGT1 (STRING, 2021; Pathway Commons, 2019; Pierce et al., 2014).